BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Biologics

YolTech Therapeutics Receives FDA Clearance to Begin Pivotal Trial for In Vivo Gene Editing Therapy in PH1

YolTech Therapeutics, a clinical-stage biotechnology company developing next-generation in vivo gene editing therapies, today announced that the U.S. Food ...

November 20, 2025 | News

AGC Biologics and Repair Biotechnologies Partner to Advance a Novel mRNA Therapy for Atherosclerotic Disease

Partnership leverages AGC Biologics’ cost-effective and dependable cGMP mRNA and LNP capabilities AGC Biologics announced it is partnering w...

November 20, 2025 | News

Bio Techne Licenses AI Designed NovoBody Duo Molecules Under Exclusive Agreement With Monod Bio

Partnership strengthens Bio-Techne's leadership in AI-enabled protein innovation NovoBody™ Duo molecules offer multi-specific binding capabilities...

November 19, 2025 | News

AbbVie Secures Approval for EPKINLY in Combination With R2 as the First Bispecific Therapy for Relapsed or Refractory Follicular Lymphoma

EPKINLY plus rituximab and lenalidomide (EPKINLY + R2) is now the first and only bispecific antibody combination therapy available f...

November 19, 2025 | News

10x Genomics And ASTRA Consortium Launch Asia Pacific Pan Cancer Spatial Atlas To Advance Precision Oncology

Initiative led by researchers in Australia and Japan aims to map cancer and immune interactions to advance precision oncology across the region 10x Genomi...

November 19, 2025 | News

Shanghai Henlius and Organon Achieve FDA Approval for POHERDY, First Pertuzumab Biosimilar in the US

Shanghai Henlius Biotech, Inc. (2696.HK), and Organon (NYSE: OGN) announced that the US Food and Drug Administration (FDA) has approved the Biologics...

November 19, 2025 | News

Terumo BCT Achieves Breakthrough in Automated T Cell Therapy Manufacturing

Terumo Blood and Cell Technologies (Terumo BCT), a global leader in cell and gene therapy technologies, announced an advancement in T cell therapy manufact...

November 19, 2025 | News

Ono Opens New Zug Office to Support Strategic Expansion Across the EMEA Region

Ono Pharmaceutical Co., Ltd. announced the opening of a new 733-square-meter office in Zug, Switzerland, to accommodate the company’s growth in Europ...

November 18, 2025 | News

Evonik and InVitria Partner to Expand Global Supply of Animal Component-Free Recombinant HSA

Expanded supply of animal component-free human serum albumin for advanced therapies and next-generation biopharmaceutical processes Safer, more consiste...

November 18, 2025 | News

PRISM BioLab Reaches Initial Milestone in Joint Oncology Research under Agreement with Ono Pharmaceutical

PRISM BioLab, Co. Ltd. ("PRISM") announces that , PRISM and Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka; President and COO: Toichi Takino; hereinafte...

November 17, 2025 | News

Volta Labs Expands Callisto Automation Through Strategic Partnership with New England Biolabs

Volta Labs, a leader in automation for genomics, and New England Biolabs® (NEB®), a world-renowned provider of life science reagents,&nb...

November 17, 2025 | News

BostonGene and Kyoto University Launch AI Collaboration to Advance Precision Treatment for Esophageal Cancer

-BostonGene, developer of the leading AI foundation model for cancer and the immune system, and Kyoto University, a research institution known for its...

November 14, 2025 | News

Teijin and BioVaram Form Strategic Alliance To Advance Regenerative Medicine and Implantable Medical Technologies Across Japan and India

Teijin Limited and BioVaram, the brand name of the UR Advanced Therapeutics Pvt Ltd. (URAT), announced today ...

November 13, 2025 | News

Vaxcellbio and Seoul National University Partner To Develop Next Generation DDS Formulation for Macular Degeneration Therapies

Vaxcellbio (CEO Je-Jung Lee, MD, PhD ), a leading immuno-oncology company, announced that it has entered into a strategic memorandum of underst...

November 13, 2025 | News

Stay Connected